Christophe Quéva Location
Cambridge, MA, US
Christophe Quéva Work
- 2022 - now Chief Scientific Officer @ DEM Biopharma, Inc.
- 2021 - now Venture Partner @ Bpifrance
- 2021 - 2022 Scientific Advisory Board member @ ISU ABXIS CO.,LTD
- 2021 - 2022 Scientific Advisory Board member @ ISU ABXIS CO.,LTD
- 2017 - 2022 Chief Scientific Officer @ Oncorus
- 2017 - 2022 Chief Scientific Officer @ Oncorus
- 2015 - 2017 Chief Scientific Officer @ iTeos Therapeutics
- 2015 - 2015 Director Biology, Translational Medicine @ Gilead Sciences
- 2012 - 2015 Director of Biology, Oncology and Inflammation @ Gilead Sciences
- 2012 - 2012 Consultant @ Scientific and strategic consulting
Christophe Quéva Education
- University of Lille 1 Sciences and Technology
PhD (Health sciences)
1989 - 1993
Christophe Quéva Skills
- Drug Discovery
- Pharmacology
- Biomarkers
- Immunology
- Oncology
- Antibodies
- Small Molecules
- Animal Models
- Cancer
- Assay Development
Christophe Quéva Summary
Christophe Quéva, based in Cambridge, MA, US, is currently a Chief Scientific Officer at DEM Biopharma, Inc.. Christophe Quéva brings experience from previous roles at Bpifrance, ISU ABXIS CO.,LTD and Oncorus. Christophe Quéva holds a 1989 - 1993 PhD in Health sciences @ University of Lille 1 Sciences and Technology. With a robust skill set that includes Drug Discovery, Pharmacology, Biomarkers, Immunology, Oncology and more. Christophe Quéva has 3 emails on RocketReach.
5 free lookup(s) per month.
No credit card required.
If you need more lookups,
subscriptions start at $48 USD/month.
Looking for a different Christophe Quéva?
Find contact details for 700 million professionals.
People Like Christophe Quéva
-
Ons Harrabi
Principle Scientist at Tallac Therapeutics
San Francisco, California, United States23 -
Jing Yang
Head of Clinical Pharmacology at Boundless Bio
Kirkland, WA, US41 -
24
-
Sabrina Genßler
Scientist at CatalYm GmbH
Bavaria, Germany1 -
Olivier Nolan-Stevaux
Senior Director at Gilead Sciences
California, United States31 -
Leila Boustany
Director at CytomX Therapeutics
South San Francisco, CA, US22 -
41
-
Yiyou Chen
Chief Scientific Officer at New Horizon Health
San Jose, CA, US25+ -
Sangtaeck Lim
Associate Director at Teva Pharmaceuticals
Philadelphia, PA, US4 -
31
-
35
-
Peter Sargent
Chief Executive Officer at Physiomics plc
London, England, GB33
Top DEM Biopharma, Inc. Employees
-
Nenad Grmusa
Chief Executive Officer at DEM Biopharma, Inc.
Cambridge, MA, US45 -
Christophe Quéva
Chief Scientific Officer at DEM Biopharma, Inc.
Cambridge, MA, US32 -
Jorge Garcia Fortanet
VP, Head of Drug Discovery at DEM Biopharma, Inc.
Cambridge, MA, US21 -
25
-
32
-
Gary Asmussen
Director, Drug Discovery at DEM Biopharma, Inc.
Cambridge, MA, US35 -
54
-
Sarah Carden
Principal Scientist, Biology at DEM Biopharma, Inc.
Boston, Massachusetts, United States13 -
21
-
51
-
David Donabedian
Founding Executive, Interim Chief Executive Officer at DEM Biopharma, Inc.
Cambridge, Massachusetts, United States55+ -
Patrick Stern
Director of Biology at DEM Biopharma, Inc.
Needham, MA, US45+
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy.
Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting.
Also available via our Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
